A South Korean pharmaceutical company medical representative confirmed

South Korean media reported that south Korean pharmaceutical industry leaders are becoming increasingly worried about one thing, as a pharmaceutical representative of a pharmaceutical company was diagnosed with COVID-19 infection this week, which could affect drug promotion activities across the industry.
a pharmaceutical representative of South Korea's Handok Pharmaceutical Company has been diagnosed with COVID-19, and two other employees of the drug company have also been diagnosed, the company said Wednesday.
This is a cluster case, the pharmaceutical representative is Handok Pharmaceuticals' pharmaceutical representative in Busan, the first confirmed case, as the representative returned to the Division's headquarters in Seoul's Gangnam district and had dinner with other employees after a visit to the headquarters, possibly in close contact with one of the employees.
the medical representative also visited doctors in Busan because of the need for promotion, Handok Pharmaceuticals said it had taken the necessary measures, such as notifying the relevant doctors to check.
To prevent the spread of the virus, Handok Pharmaceuticals closed its headquarters and sales offices in Busan after the representative was diagnosed and ordered all employees at headquarters and busan branches to work from home for a week and all employees to conduct nucleic acid testing.
Handok Pharmaceuticals is a comprehensive pharmaceutical company in Korea, founded in 1954, and multinational pharmaceutical companies have decades of cooperation history, the earliest and Germany Hested set up a joint venture, after Avant, Sanofi and other companies, The company, which partnered to obtain advanced pharmaceutical technologies and high-quality pharmaceuticals, discontinued its joint venture with Sanofi in 2012 and is currently working on bioinnovatants, targeted oncology drugs and medical devices, although existing products are still diversified, from pharmaceuticals to health care products.
in South Korea, this is not the first confirmed case of a medical representative.
In June of this year, a medical representative of the Gyeonggi Road branch of Big Bear Pharmaceuticals of Korea was diagnosed with COVID-19, when Big Bear Pharmaceuticals conducted an internal examination to determine the hospital and pharmacy visited by the representative, and in August, a representative of the Running General Hospital of Grigg Ingham Korea was also diagnosed with the infection.
south Korean industry sources said the Handok pharmaceutical infection may affect the industry's current pattern of visits, and affect the promotion of drugs.
the head of a local drug company in South Korea said that after the outbreak bes normalized, pharmaceutical companies and pharmaceutical representatives should make flexible decisions based on local conditions, and specific regions and offices could stop face-to-face visits.
▌ countries have medical representatives confirmed infection at the beginning of the year when the outbreak arrived, Dami has repeatedly reminded everyone, be sure to do a good job of protection, whether in life, or in the face of the coming work.
because there's some news I'm still relatively able to know a little bit more than you do.
After, in our severe outbreak period, there have been a number of confirmed cases of medical people, the public reports are Lianyungang City, Hubei Danjiangkou City, Hebei City, Shijiazhuang City, Jiangsu Province, Chengdu, Sichuan And so on.
the outbreak in Beijing in June this year, another employee of a pharmaceutical company was diagnosed.
has previously shared some of Japan's peer-diagnosed cases with her partner.
April 13 this year, the First Third Communist Party of Japan headquarters issued a notice announcing that an employee of Toyama's office had been diagnosed with the new coronavirus.
the employee, who has been hospitalized for injuries since March 31, underwent a PCR test during his stay and tested positive on April 12.
At that time, the first three said that because the employee was hospitalized with injuries, he had not visited a medical facility recently, and that no other employees had been contacted by visits during this period, so it would not be transmitted to other office employees.
August 3rd this year, another Japanese pharmaceutical company, Astellas Japan, announced that two employees working in the Naha city office and the Kyoto city office had been diagnosed with the new coronavirus.
this, due to cold symptoms, two employees went to the hospital for a check-up, after a PCR examination, the two were diagnosed with the infection on August 1st, and are currently recuperation at home.
Astellas said there was no contact between the two employees and that the company was taking the following urgent measures: To investigate, identify and communicate the trajectory of the employees who were diagnosed with the infection and the persons who may have had strong contact, as required by the health care facility.
. For employees who may have strong contact, work is prohibited and work from home.
, in consultation with the Health Care Institute, to work with outside company personnel who may have strong contact with two employees to minimize the risk of infection.
is now in winter again, and this week's south Korean thing is another reminder that travel must be personally protected and careful.